World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
70
Citations
37782
World Ranking
20041
National Ranking
1803

Eric L. Michelson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Eric L. Michelson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 230 publications — 5th percentile

5% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Eric L. Michelson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Eric L. Michelson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 70 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Eric L. Michelson is affiliated with AstraZeneca in the United Kingdom. Their professional background is connected to the pharmaceutical industry, based on the primary affiliation with a multinational biopharmaceutical company focused on scientific research and development.

There is no specific data available regarding published research papers, co-authors, or frequent publication venues. Similarly, there are no records of book publications or detailed information about the main fields or subfields of study related to Michelson's work.

Information on scientific topics or research areas that Michelson has extensively worked on is also not provided. Likewise, details about awards or honors are absent from the available data.

Owing to the nature of the affiliation, it is reasonable to associate Michelson's professional activities with pharmaceutical research, drug development, or related biomedical sciences; however, no explicit details confirm particular fields of specialization or research themes.

Best Publications

  • Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

    Christopher B Granger;John J V McMurray;Salim Yusuf;Peter Held

  • Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

    Salim Yusuf;Marc A Pfeffer;Karl Swedberg;Christopher B Granger

  • Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

    Marc A Pfeffer;Karl Swedberg;Christopher B Granger;Peter Held

  • Fast track — ArticlesEffects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

    Christopher B Granger;John Jv McMurray;Salim Yusuf;Peter Held

  • CHARM IN-VESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION TAKING ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS: THE CHARM-ADDED TRIAL

    J J Mcmurray;J Ostergren;K Swedberg;C B Granger

  • Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank.

    G. Michael Felker;Larry A. Allen;Stuart J. Pocock;Linda K. Shaw

  • Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker

    Stevo Julius;Shawna D. Nesbitt;Brent M. Egan;Michael A. Weber

  • Predictors of mortality and morbidity in patients with chronic heart failure

    Stuart J Pocock;Duolao Wang;Marc A Pfeffer;Salim Yusuf

  • Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure

    Hans L. Hillege;Dorothea Nitsch;Marc A. Pfeffer;Karl Swedberg

  • Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients

    Scott D Solomon;Nagesh Anavekar;Hicham Skali;John J V McMurray

  • Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency.

    J Morganroth;E L Michelson;L N Horowitz;M E Josephson

  • Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.

    Michael R. MacDonald;Mark C. Petrie;Fumi Varyani;Jan Östergren

  • Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure.

    Scott D. Solomon;Joanna Dobson;Stuart Pocock;Hicham Skali

  • Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction : Results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program

    Lars G. Olsson;Karl Swedberg;Anique Ducharme;Christopher B. Granger

  • Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.

    L N Horowitz;M E Josephson;A Farshidi;S R Spielman

  • CHARM INVESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND PRESERVED LEFT-VENTRICULAR EJECTION FRACTION: THE CHARM-PRESERVED TRIAL

    S Yusuf;Pfeffer;K Swedberg;C B Granger

  • Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial.

    Bradi B Granger;Karl Swedberg;Inger Ekman;Christopher B Granger

  • Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction Results of the CHARM Low-Left Ventricular Ejection Fraction Trials

    James B. Young;Mark E. Dunlap;Marc A. Pfeffer;Jeffrey L. Probstfield

  • Recurrent sustained ventricular tachycardia. 4. Pleomorphism.

    M E Josephson;L N Horowitz;A Farshidi;S R Spielman

  • Effects of candesartan on mortality and morbidity in patients with chronic heart failure

    MA Pfeffer;K Swedberg;CB Granger;P Held

Frequent Co-Authors

Salim Yusuf
Salim Yusuf McMaster University
Marc A. Pfeffer
Marc A. Pfeffer Harvard Medical School
John J.V. McMurray
John J.V. McMurray University of Glasgow
Karl Swedberg
Karl Swedberg University of Gothenburg
Christopher B. Granger
Christopher B. Granger Duke University
Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
Stuart J. Pocock
Stuart J. Pocock London School of Hygiene & Tropical Medicine
James B. Young
James B. Young Cleveland Clinic
Christopher P. Cannon
Christopher P. Cannon Brigham and Women's Hospital
Robert F. Storey
Robert F. Storey University of Sheffield

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical education in the USA opens doors to a range of online degree options and alternative career pathways. Many healthcare professionals consider bridging their credentials. For example, registered nurses often look into adn to fnp programs to advance their skills and become Family Nurse Practitioners. These pathways offer flexible online options for working professionals.

An online degree in nutrition is another popular choice, preparing graduates for careers in dietetics, public health, and wellness coaching. For those interested in the business side of healthcare, selecting a cahme-accredited online Master of Health Administration program ensures a rigorous and credible educational experience.

Nurses seeking additional credentials can benefit from flexible rn to bsn programs with no required clinicals, allowing them to enhance their qualifications entirely online. These related degrees are ideal for those aiming to expand their expertise or shift specialties within the healthcare field.

Best Scientists Citing Eric L. Michelson

Trending Scientists

Recently Published Articles